EA200100370A1 - Способ предотвращения или отсрочки катетерной реваскуляризации - Google Patents

Способ предотвращения или отсрочки катетерной реваскуляризации

Info

Publication number
EA200100370A1
EA200100370A1 EA200100370A EA200100370A EA200100370A1 EA 200100370 A1 EA200100370 A1 EA 200100370A1 EA 200100370 A EA200100370 A EA 200100370A EA 200100370 A EA200100370 A EA 200100370A EA 200100370 A1 EA200100370 A1 EA 200100370A1
Authority
EA
Eurasian Patent Office
Prior art keywords
revascularization
cathetric
adults
prevention
delays
Prior art date
Application number
EA200100370A
Other languages
English (en)
Other versions
EA007427B1 (ru
Inventor
Дональд Майкл Блэк
Original Assignee
Варнер Ламберт Компани
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22289955&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA200100370(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Варнер Ламберт Компани filed Critical Варнер Ламберт Компани
Publication of EA200100370A1 publication Critical patent/EA200100370A1/ru
Publication of EA007427B1 publication Critical patent/EA007427B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Surgical Instruments (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Media Introduction/Drainage Providing Device (AREA)

Abstract

Активное снижение содержания холестерина у пациентов, страдающих заболеваниями коронарных артерий, предотвращает или задерживает необходимость в катетерной реваскуляризации.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA200100370A 1998-09-30 1999-07-08 Способ предотвращения или отсрочки катетерной реваскуляризации EA007427B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10245798P 1998-09-30 1998-09-30
PCT/US1999/015385 WO2000018395A1 (en) 1998-09-30 1999-07-08 Method for preventing or delaying catheter-based revascularization

Publications (2)

Publication Number Publication Date
EA200100370A1 true EA200100370A1 (ru) 2001-10-22
EA007427B1 EA007427B1 (ru) 2006-10-27

Family

ID=22289955

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200100370A EA007427B1 (ru) 1998-09-30 1999-07-08 Способ предотвращения или отсрочки катетерной реваскуляризации

Country Status (35)

Country Link
US (1) US20080119561A1 (ru)
EP (1) EP1117392B1 (ru)
JP (1) JP2002525321A (ru)
KR (1) KR20010079955A (ru)
CN (1) CN1197565C (ru)
AP (1) AP1708A (ru)
AT (1) ATE260100T1 (ru)
AU (1) AU768474B2 (ru)
BG (1) BG105471A (ru)
BR (1) BR9914098A (ru)
CA (1) CA2343299C (ru)
CZ (1) CZ20011035A3 (ru)
DE (1) DE69915084T2 (ru)
DK (1) DK1117392T3 (ru)
EA (1) EA007427B1 (ru)
EE (1) EE200100199A (ru)
ES (1) ES2214872T3 (ru)
HK (1) HK1042436A1 (ru)
HR (1) HRP20010236A2 (ru)
HU (1) HUP0103648A3 (ru)
ID (1) ID30255A (ru)
IL (2) IL141953A0 (ru)
IS (1) IS5889A (ru)
NO (1) NO20011615L (ru)
NZ (1) NZ510500A (ru)
OA (1) OA11787A (ru)
PL (1) PL346980A1 (ru)
PT (1) PT1117392E (ru)
SI (1) SI1117392T1 (ru)
SK (1) SK4122001A3 (ru)
TR (1) TR200100901T2 (ru)
UA (1) UA73292C2 (ru)
WO (1) WO2000018395A1 (ru)
YU (1) YU23901A (ru)
ZA (1) ZA200102230B (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001256278A1 (en) * 2000-04-18 2001-10-30 Bayer Aktiengesellschaft Use of cse inhibitors for treating heart failure
US20030212118A1 (en) * 2000-07-14 2003-11-13 Auerbach Bruce Jeffrey Treatment of eating disorders using carboxyalkylethers

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5157025A (en) * 1991-04-01 1992-10-20 E. R. Squibb & Sons, Inc. Method for lowering serum cholesterol employing a phosphorus containing ace inhibitor alone or in combination with a cholesterol lowering drug
US5807388A (en) * 1994-05-25 1998-09-15 The Trustees Of Columbia University In The City Of New York Myocardial revascularization through the endocardial surface using a laser
WO1995013063A1 (en) * 1993-11-09 1995-05-18 Merck & Co., Inc. HMG-CoA REDUCTASE INHIBITORS IN THE NORMALIZATION OF VASCULAR ENDOTHELIAL DYSFUNCTION
US5545628A (en) * 1995-01-10 1996-08-13 Galephar P.R. Inc. Pharmaceutical composition containing fenofibrate
US5648387A (en) * 1995-03-24 1997-07-15 Warner-Lambert Company Carboxyalkylethers, formulations, and treatment of vascular diseases
KR20040029459A (ko) * 1995-11-02 2004-04-06 워너-램버트 캄파니 엘엘씨 지질 농도를 조절하는 제약 조성물 및 방법
SE506272C2 (sv) * 1996-03-18 1997-11-24 Paul Edholm Förfarande och anordning för att bestämma bildläge och bildvinkel i en röntgenbild
IL117702A0 (en) * 1996-03-28 1996-07-23 Tel Aviv Medical Center Resear Drug for hyperlipoproteinemia
WO1998001116A1 (en) * 1996-07-09 1998-01-15 Merck & Co., Inc. Therapy for combined hyperlipidemia
US5861399A (en) * 1996-07-17 1999-01-19 Heart Care Partners Methods and compositions for the rapid and enduring relief of inadequate myocardial function
US6180660B1 (en) * 1997-08-26 2001-01-30 Merck & Co., Inc. Cholesterol-lowering therapy
NZ503982A (en) * 1997-12-12 2002-03-28 Warner Lambert Co Statin-carboxyalkylether combinations useful for treating vascular disorders and diabetes mellitus

Also Published As

Publication number Publication date
JP2002525321A (ja) 2002-08-13
CN1342072A (zh) 2002-03-27
EP1117392B1 (en) 2004-02-25
AP2001002112A0 (en) 2001-06-30
TR200100901T2 (tr) 2001-08-21
EE200100199A (et) 2002-06-17
ID30255A (id) 2001-11-15
AU4975099A (en) 2000-04-17
UA73292C2 (en) 2005-07-15
CZ20011035A3 (cs) 2001-10-17
NO20011615D0 (no) 2001-03-29
IS5889A (is) 2001-03-14
NO20011615L (no) 2001-04-24
DE69915084D1 (de) 2004-04-01
PT1117392E (pt) 2004-07-30
EP1117392A1 (en) 2001-07-25
PL346980A1 (en) 2002-03-11
DE69915084T2 (de) 2004-07-22
CA2343299C (en) 2008-04-01
ES2214872T3 (es) 2004-09-16
US20080119561A1 (en) 2008-05-22
IL141953A (en) 2006-07-05
NZ510500A (en) 2003-10-31
OA11787A (en) 2005-07-26
SK4122001A3 (en) 2002-06-04
SI1117392T1 (en) 2004-06-30
YU23901A (sh) 2003-07-07
IL141953A0 (en) 2002-03-10
ATE260100T1 (de) 2004-03-15
HK1042436A1 (en) 2002-08-16
BR9914098A (pt) 2001-07-31
KR20010079955A (ko) 2001-08-22
WO2000018395A1 (en) 2000-04-06
EA007427B1 (ru) 2006-10-27
AP1708A (en) 2007-01-10
HUP0103648A3 (en) 2003-10-28
AU768474B2 (en) 2003-12-11
CN1197565C (zh) 2005-04-20
BG105471A (en) 2001-12-31
ZA200102230B (en) 2002-06-18
HUP0103648A2 (hu) 2003-08-28
DK1117392T3 (da) 2004-06-14
CA2343299A1 (en) 2000-04-06
HRP20010236A2 (en) 2002-04-30

Similar Documents

Publication Publication Date Title
ITTO950104A0 (it) Catetere, particolarmente per il trattamento di aritmie cardiache.
ITSV980070A0 (it) Sistema endovascolare per il trattamento delle stenosi carotidee e catetere per tale sistema.
NL1002223C2 (nl) Dilatatiekatheter met zijopening.
DK1207819T3 (da) Rörformet transplantatkonstruktion
DK1066056T4 (da) Jerndextranforbindelse til anvendelse som komponent i et terapeutisk middel til forebyggelse af eller behandling af jernmangel, fremgangsmåde til fremstilling af jerndextranforbindelsen og anvendelse af denne forbindelse til fremstilling af et...
DK0658348T3 (da) Vandige opløsninger af inklusionskomplekser af benzothiophenforbindelser og cyclodextriner
ITTO950099A0 (it) Catetere, particolarmente per il trattamento di aritmie cardiache.
DE69115003D1 (de) Fettfreies reibungsarmes Lager.
DE69828004D1 (de) Katheter für die rechte Koronararterie
IT1308743B1 (it) Suola di cingolo.
DE69935873D1 (de) 2-Methyl-thieno-benzodiazepin Formulierung
FR2719224B1 (fr) Cathéter de dilatation à échange rapide.
ATE363920T1 (de) Hydrophobe iodverbindung enthaltende liposome
IT242974Y1 (it) Guida di estrazione per cassetto.
EA200100370A1 (ru) Способ предотвращения или отсрочки катетерной реваскуляризации
BR0014916A (pt) Solução de agente para dourar de fumaça lìquida aperfeiçoada
DK1133314T3 (da) Protein C til behandling af seglcellesygdom og thalassæmi
PT1408035E (pt) Metodo de preparacao de derivativos de 1.5-diaril-3-trifluorometilo-delta2-pirazolinas que sejam racemicos e enanciomericamente puros
FR2786685B1 (fr) Extenseurs vasculaires et coronaires, habituellement designes sous le nom de "stent"
NO20012849D0 (no) Ny terapeutisk anvendelse for hepariner med lav molekylvekt
ATE222103T1 (de) Inklusionskomplexe in waessriger loesung
IT1288275B1 (it) Guida di estrazione per cassetto.
IT1303271B1 (it) Piedino di sostegno perfezionato per armadi e simili.
FR2720270B1 (fr) Genouillère médicale.
BR9601742A (pt) Conjunto de suportes guias para montagem de armário estantes e congêneres

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU